MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
7.74
-0.03
-0.32%
Opening 12:08 11/14 EST
OPEN
7.80
PREV CLOSE
7.77
HIGH
7.94
LOW
7.55
VOLUME
3.39M
TURNOVER
--
52 WEEK HIGH
23.86
52 WEEK LOW
3.532
MARKET CAP
1.24B
P/E (TTM)
-2.8007
1D
5D
1M
3M
1Y
5Y
1D
Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway
Seeking Alpha · 1d ago
Novavax price target lowered to $9 from $14 at TD Cowen
TipRanks · 1d ago
HC Wainwright & Co. Reiterates Buy on Novavax, Maintains $19 Price Target
Benzinga · 1d ago
Novavax price target lowered to $12 from $14 at BofA
TipRanks · 1d ago
Novavax’s Market Share and Pipeline Uncertainties Lead to Sell Rating
TipRanks · 1d ago
Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook
TipRanks · 1d ago
NVAX Earnings: Novavax Stock Down on Weak 2024 Revenue Outlook
TipRanks · 1d ago
NOVAVAX INC <NVAX.O>: TD COWEN CUTS TARGET PRICE TO $9 FROM $14
Reuters · 1d ago
More
About NVAX
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.